Cepheida receives approval for its bacterial diagnostic test
Molecular-diagnostic company Cepheid has received the Food and Drug Administration (FDA) approval for a test that helps in rapid diagnosis of a bacteria linked to antibiotic-resistant infections. Cepheid’s Xpert C.difficile test can detect within 45 minutes a bacterium that causes the Clostridium difficile infection, resulting in diarrhea and more serious intestinal conditions, such as colitis.
- Roche Gets FDA Ok For LightCycle Test
- Endologix Receives CE Mark Approval For Expanded Line Of Powerlink Products And PowerFit Aortic Extensions
- InfraScan receives CE Mark for handheld detector
- Abbott Receives 510(k) Clearance For CT/NG Assay And Abbott m2000 System
